Press release from Companies: Aptahem erhåller patentskydd i Japan för patentfamilj 2

Reports: Aptahems bokslutskommuniké 2021-01-01 till 2021-12-31

Press release from Companies: Aptahem appoints CMC Director

Press release from Companies: Aptahem utser CMC Director

Press release from Companies: Aptahem appoints new COO

Press release from Companies: Aptahem utser ny COO

Press release from Companies: Aptahem stärker teamet och utser en Regulatory Affairs Director

Press release from Companies: Aptahem signs start up agreement with international clinical CRO for phase 1 studies with Apta-1

Press release from Companies: Aptahem har ingått uppstartsavtal med internationell klinisk CRO för fas 1 studier med Apta-1

Press release from Companies: BioStock article: Aptahem’s CEO on clinical studies in 2022

Press release from Companies: BioStock-artikel: Aptahems vd om kliniska studier under 2022

Press release from Companies: Aptahem’s patent family 2 in Europe has been finalized by validation in the 11 countries where applied